These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17637398)

  • 21. The impact of different dose-response parameters on biologically optimized IMRT in breast cancer.
    Ferreira BC; Mavroidis P; Adamus-Górka M; Svensson R; Lind BK
    Phys Med Biol; 2008 May; 53(10):2733-52. PubMed ID: 18448874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses.
    Nguyen J; Moteabbed M; Paganetti H
    Med Phys; 2015 Jan; 42(1):81-9. PubMed ID: 25563249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity.
    Coote JH; Wylie JP; Cowan RA; Logue JP; Swindell R; Livsey JE
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1121-7. PubMed ID: 19131179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of changing technique, dose, and PTV margin on therapeutic ratio during prostate radiotherapy.
    Huang SH; Catton C; Jezioranski J; Bayley A; Rose S; Rosewall T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1057-64. PubMed ID: 18339487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation doses and risks from internal emitters.
    Harrison J; Day P
    J Radiol Prot; 2008 Jun; 28(2):137-59. PubMed ID: 18495991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment and minimization of contralateral breast dose for conventional and intensity modulated breast radiotherapy.
    Burmeister J; Alvarado N; Way S; McDermott P; Bossenberger T; Jaenisch H; Patel R; Washington T
    Med Dosim; 2008; 33(1):6-13. PubMed ID: 18262117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.
    Yuen J; Rodrigues G; Trenka K; Coad T; Yartsev S; D'Souza D; Lock M; Bauman G
    Radiat Oncol; 2008 Jan; 3():1. PubMed ID: 18179695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.
    Johansen S; Danielsen T; Olsen DR
    Acta Oncol; 2008; 47(3):391-6. PubMed ID: 18348001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer.
    Sanguineti G; Endres EJ; Parker BC; Bicquart C; Little M; Chen G; Berilgen J
    Acta Oncol; 2008; 47(2):301-10. PubMed ID: 18210303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
    Vargas C; Fryer A; Mahajan C; Indelicato D; Horne D; Chellini A; McKenzie C; Lawlor P; Henderson R; Li Z; Lin L; Olivier K; Keole S
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):744-51. PubMed ID: 17904306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncertainties in internal dose calculations for radiopharmaceuticals.
    Stabin MG
    J Nucl Med; 2008 May; 49(5):853-60. PubMed ID: 18413398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of a peripheral dose among various linac geometries for second cancer risk assessment.
    Joosten A; Bochud F; Baechler S; Levi F; Mirimanoff RO; Moeckli R
    Phys Med Biol; 2011 Aug; 56(16):5131-51. PubMed ID: 21775792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.
    Fonteyne V; Villeirs G; Lumen N; De Meerleer G
    Radiother Oncol; 2009 Jul; 92(1):42-7. PubMed ID: 19356817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk.
    Stabin MG
    J Nucl Med; 2008 Sep; 49(9):1555-63. PubMed ID: 18765586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.